Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The medication's mechanism of action targets metabolic pathways rather than immune or inflammatory processes central to MS pathophysiology
It deliberately doesn't name a weight threshold or BMI requirement on the homepage - the clinical determination happens during the intake review
This can provide flexibility but lacks the rigorous testing undergone by FDA-approved versions like Wegovy
Our program is tailored to individual needs, making it suitable for most people
This newsletter is for clinical and educational purposes
As of 2024, the MHRA (Medicines and Healthcare products Regulatory Agency) has authorised Mounjaro for use in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, such as hypertension, dyslipidaemia, or obstructive sleep apnoea
US$ 26.38
US$ 21.43
US$ 27.08
US$ 20.63
US$ 26.49
US$ 22.05
US$ 25.61
